Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Therapy for the Treatment of Chest Wall Progression of Breast Cancer

NCT01262716 is registered in ClinicalTrials.gov with Rogers Sciences Inc. as lead sponsor.

NCT NCT01262716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01262716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Therapy for the Treatment of Chest Wall Progression of Breast Cancer
Lead sponsor
Rogers Sciences Inc.
Phase
Observational
Overall status
Completed
Start date
December 31, 2010
Completion date
August 31, 2011
Enrollment
3 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer